Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-TAT-2022-1000x250

The ESMO TAT Congress 2022 Exhibition is the leading platform to showcase the latest research in the field.

This is an outstanding occasion to promote the value of your products and services both in an onsite and online setting.

For information about the exhibition for ESMO TAT Congress 2022, please download our Exhibitor Manual below: 

Download the ESMO TAT Congress 2022 Exhibitor Manual

Contacts

Onsite and Online Exhibition Support

ESMO TAT Congress 2022 Secretariat
ESMO Head Office
Tel: +41 (0)91 973 19 47/ 90
E-mail: symposia@esmo.org

Official Italian agency for AIFA procedure

AIFA rules are mandatory only for Italian Pharmaceutical Companies that will attend a congress abroad.

Any pharmaceutical company supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the even.

ESMO advises pharmaceutical companies to contact the Official Agency:

AIM Group International – AIM Education S.r.l.
Contact: Cristina Ghidoli
Via G. Ripamonti, 129
20141 Milan – Italy
Tel.: +39 02 56601 1
Fax.: +39 02 70048585
E-mailaifa@aimgroup.eu

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings